News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
159 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21087)
Month
January (2987)
February (3289)
March (3625)
April (3424)
May (3732)
June (3552)
July (2687)
August (3042)
September (3454)
October (3101)
November (3075)
December (2362)
Day
3 (172)
4 (195)
5 (149)
6 (140)
7 (113)
10 (126)
11 (159)
12 (120)
13 (172)
14 (93)
17 (155)
18 (157)
19 (135)
20 (154)
21 (99)
24 (148)
25 (174)
26 (164)
27 (205)
28 (128)
31 (143)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
3
4
5
6
7
10
11
12
13
14
17
18
19
20
21
24
25
26
27
28
31
Policy
Neurocrine Biosciences Announces INGREZZA (Valbenazine) New Drug Application For The Treatment Of Tardive Dyskinesia Has Been Accepted For Priority Review By U.S. FDA
October 11, 2016
·
5 min read
Drug Development
Merrimack Release: Final Results Of NAPOLI-1 Study Confirm Overall Survival And Progression-Free Survival Benefit For The ONIVYDE Regimen For Patients With Metastatic Pancreatic Cancer
October 11, 2016
·
17 min read
Drug Development
Delcath Systems Announces New U.S. Clinical Sites For FOCUS Phase 3 Trial For Ocular Melanoma Liver Metastases
October 11, 2016
·
5 min read
St. Jude Children’s Research Hospital Release: Triple-Drug Chemotherapy With Topotecan Helps Preserve Vision In Retinoblastoma Patients
October 11, 2016
·
5 min read
Biotech Bay
Rigel Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
October 11, 2016
·
2 min read
BioMidwest
Rebiotix Receives Patent From The USPTO For Microbiota Restoration Therapy
October 11, 2016
·
2 min read
Business
Reata Pharmaceuticals, Inc. Appoints Dawn Carter Bir As Vice President And Chief Commercial Officer
October 11, 2016
·
3 min read
BioMidwest
Cellectar Biosciences To Present At SeeThru Equity And Dawson James Investor Conferences
October 11, 2016
·
3 min read
China Biologic Products Receives CFDA Clinical Trial Approval For Human Antithrombin III
October 11, 2016
·
4 min read
Policy
Allergan Release: FDA Accepts Supplemental New Drug Application (sNDA) For AVYCAZ (Ceftazidime And Avibactam)
October 11, 2016
·
12 min read
Previous
3 of 16
Next
